MASLD
0
0
September 16, 2026 3 min read ...
admin
0
0
As incretin-based therapies and metabolic pharmacology become more embedded in everyday care, gastroenterologists are encountering new challenges—and ...
0
0
Global MASLD Consensus: Inclusive in Scope, Exclusive in Therapy?